Review article: the pathogenesis and management of eosinophilic oesophagitis

被引:70
作者
Furuta, G. T. [1 ]
Straumann, A. [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA
关键词
D O I
10.1111/j.1365-2036.2006.02984.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Eosinophilic oesophagitis is a clinicopathological disease affecting both children and adults that is characterized by symptoms of gastro-oesophageal reflux disease (feeding refusal, vomiting, heartburn, dysphagia and food impaction) and dense oesophageal eosinophilia both of which are unresponsive to proton pump inhibition. AimTo present a review of the recent literature examining the pathogenesis and treatments of eosinophilic oesophagitis. Methods We performed a PubMed search for eosinophilic oesophagitis, pathogenesis and treatments. Results Translational and basic studies suggest that this disease is sparked by food or by aeroallergens. To date, effective treatments include systemic/topical corticosteroids, specific food elimination or an elemental diet. While several studies identified oesophageal strictures as potential complications of unbridled eosinophilia, the natural history of the disease is still not certain. Recent studies suggest a role for interleukin-5 and eotaxin-3 in the pathogenesis of eosinophilic oesophagitis and suggest an impact of future targeted therapeutic agents. Conclusions Eosinophilic oesophagitis represents a immune-mediated disease of undetermined pathogenesis. While many patients develop clinicopathological findings following ingestion of foods, others do not. Natural history studies will be critical to defining future treatment paradigms.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 77 条
[1]   Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice [J].
Akei, HS ;
Mishra, A ;
Blanchard, C ;
Rothenberg, ME .
GASTROENTEROLOGY, 2005, 129 (03) :985-994
[2]   Eosinophilic Esophagitis: Asthma of the Esophagus? [J].
Arora, Amindra S. ;
Yamazaki, Kiyoshi .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (07) :523-530
[3]   Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults [J].
Arora, AS ;
Perrault, J ;
Smyrk, TC .
MAYO CLINIC PROCEEDINGS, 2003, 78 (07) :830-835
[4]   ESOPHAGEAL EOSINOPHILIA WITH DYSPHAGIA - A DISTINCT CLINICOPATHOLOGICAL SYNDROME [J].
ATTWOOD, SEA ;
SMYRK, TC ;
DEMEESTER, TR ;
JONES, JB .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (01) :109-116
[5]   Eosinophilic oesophagitis: a novel treatment using Montelukast [J].
Attwood, SEA ;
Lewis, CJ ;
Bronder, CS ;
Morris, CD ;
Armstrong, GR ;
Whittam, J .
GUT, 2003, 52 (02) :181-185
[6]   Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis [J].
Blanchard, C ;
Wang, N ;
Stringer, KF ;
Mishra, A ;
Fulkerson, PC ;
Abonia, JP ;
Jameson, SC ;
Kirby, C ;
Konikoff, MR ;
Collins, MH ;
Cohen, MB ;
Akers, R ;
Hogan, SP ;
Assa'ad, AH ;
Putnam, PE ;
Aronow, BJ ;
Rothenberg, ME .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (02) :536-547
[7]   Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354) [J].
Blanchard, C ;
Mishra, A ;
Saito-Akei, H ;
Monk, P ;
Anderson, I ;
Rothenberg, ME .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (08) :1096-1103
[8]  
Bonis PAL, 2001, AM J GASTROENTEROL, V96, P3439
[9]   Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults:: an association in two cases [J].
Cantù, P ;
Velio, P ;
Prada, A ;
Penagini, R .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (02) :129-134
[10]   Clinical and endoscopic features of eosinophilic esophagitis in adults [J].
Croese, J ;
Fairley, SK ;
Masson, JW ;
Chong, AKH ;
Whitaker, DA ;
Kanowski, PA ;
Walker, NI .
GASTROINTESTINAL ENDOSCOPY, 2003, 58 (04) :516-522